Pharma news
Americas
Pharmaceutical companies have entered into fewer ‘pay-for-delay’ patent settlements since the US Supreme Court said such agreements could violate anti-competition laws, a report has claimed. 14 January 2016
Americas
US politicians have called on the National Institute of Health to reveal when it would use its right to make companies license certain patents in order to stop drugs being priced too high. 12 January 2016
Americas
Law firm Orrick, Herrington & Sutcliffe has added Richard DeLucia, Elizabeth Gardner, Antony Pfeffer and Patrick Herman to the firm’s patent litigation group in New York. 12 January 2016
Americas
The manner in which some Canadian judges have applied the ‘promise’ doctrine has been criticised as arbitrary and subjective, note Declan Hamill and Megan Kendall of Innovative Medicines Canada, the association of Canada’s innovative pharmaceutical industry. 7 January 2016
Pharma
UK law firm Potter Clarkson has elected Michael Pears as partner in the firm’s biotechnology and pharmaceuticals department. 5 January 2016
Asia
Roche has settled its patent litigation dispute with India-based Glenmark Pharmaceuticals centring on cancer drug Tarceva. 4 January 2016
Pharma
Germany-based healthcare company Bayer HealthCare has sued Mylan Pharmaceuticals over the alleged infringement of five of its patents. 22 December 2015
Pharma
India-based life sciences company Glenmark Pharmaceuticals has confirmed that it has ended its patent dispute with Forest Laboratories. 21 December 2015
Pharma
The US Court of Appeals for the Federal Circuit’s affirmation of the Patent Trial and Appeal Board’s decision to invalidate a Merck patent used to reduce homocysteine in the human body faced criticism from a dissenting judge, who claimed the court showed too much deference to the body’s decision. 18 December 2015
Pharma
The complex rules around the filing of divisional applications relating to priority of patent claims are designed to maintain the integrity of the first-to-file system, as Ashley Roughton of Nabarro explains. 17 December 2015